10X Genomics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $166,030 | $149,002 | $172,908 | $154,883 |
Gross Profit | 113,045 | 100,307 | 125,084 | 105,445 |
EBITDA | -19,541 | -15,951 | 46,651 | -23,692 |
EBIT | -28,202 | 37,000 | -33,506 | |
Net Income | -16,252 | -27,472 | 34,538 | -34,358 |
Net Change In Cash | 166,030 | 149,002 | 172,908 | 154,883 |
Free Cash Flow | 39,000 | 42,527 | 16,130 | 32,458 |
Cash | 473,966 | 432,508 | 397,712 | 377,061 |
Basic Shares | 127,078 | 125,502 | 124,509 | 122,606 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $642,823 | $610,785 | $618,727 | $516,409 |
Gross Profit | 443,881 | 414,482 | 409,313 | 396,023 |
EBITDA | -110,885 | -133,988 | -205,111 | -128,489 |
EBIT | -177,696 | -248,730 | -161,495 | |
Net Income | -43,544 | -182,627 | -255,099 | -166,000 |
Net Change In Cash | 642,823 | 610,785 | 618,727 | 516,409 |
Cost of Revenue | -368,676 | |||
Free Cash Flow | 130,115 | -5,729 | -64,721 | -165,267 |
Cash | 473,966 | 344,067 | 359,284 | 219,746 |
Basic Shares | 124,749 | 120,451 | 117,165 | 113,858 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | $0.07 |
2025-09-30 | -$0.02 |
2025-06-30 | $0.28 |
